| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |